# 2026-18954: Uncle Sam Invents Killer Antibody for Baby-Lung Virus RSV

2026-18954, Government-Owned Inventions; Availability for Licensing, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2026-09-16, effective 2026-09-16 (as of 2026-09-23).

- Canonical: https://policyrisk.com/federal-register/2026-18954
- As of: 2026-09-23
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-18954
- Title: Government-Owned Inventions; Availability for Licensing
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 91 FR 58689
- Published: 2026-09-16
- Effective: 2026-09-16
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-23

## In one line

Uncle Sam Invents Killer Antibody for Baby-Lung Virus RSV

## Summary

The National Institutes of Health is offering a new, powerful antibody invention that targets a tricky part of the RSV virus, which causes serious lung infections. This new tech could help companies create better treatments or preventions, especially for babies and older adults. Licensing is open now, with some foreign patent options, so businesses can jump in and start making a difference—and money—fast!

## Abstract

The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the invention listed below, which is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20771](https://policyrisk.com/federal-register/2026-20771): Center for Scientific Review; Notice of Closed Meetings, 2026-10-09
- [2026-20705](https://policyrisk.com/federal-register/2026-20705): Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With…, 2026-10-09
- [2026-20424](https://policyrisk.com/federal-register/2026-20424): National Cancer Institute; Notice of Meeting, 2026-10-06
- [2026-20365](https://policyrisk.com/federal-register/2026-20365): Center For Scientific Review; Notice of Closed Meetings, 2026-10-05
- [2026-20151](https://policyrisk.com/federal-register/2026-20151): Notice of NIH Tribal Consultations and Listening Session, 2026-10-01
- [2026-19719](https://policyrisk.com/federal-register/2026-19719): Center for Scientific Review; Amended Notice of Meeting, 2026-09-28

## Sources
- [2026-18954 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/16/2026-18954/government-owned-inventions-availability-for-licensing)
- [2026-18954 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-16/pdf/2026-18954.pdf)

## Related
- [Previous: 2026-18953, Center for Scientific Review; Notice of Closed Meetings](https://policyrisk.com/federal-register/2026-18953)
- [Next: 2026-18955, Notice of Open Meeting](https://policyrisk.com/federal-register/2026-18955)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-18954 (as of 2026-09-23).